A sutdy for analyzing causative genes for common diseases in urinary tract and male sex organs
A sutdy for analyzing causative genes for common diseases in urinary tract and male sex organs
批准号:
12307034
负责人:
SHUIN Taro
金额:
$19.09万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001
中文摘要
点击翻译按钮获取中文摘要
英文摘要
there are a many common disease in the genitourinary tract organ. For example, urinary tract calculi (uric acid or, oxalic acid calcium calculi), BHP, the anormalies in infant urinary tract and in male sex organs, the genitourinary tract cancer, and male sterility are such kinds of disease. It is difficult to explain such kinds of diseases as single gene diseases such as recessive or dominant hereditary diseases. These are regarded as multifactor diseases. The causative genes in these diseases are not known yet. It is important for us to accumulate DNA from the organs or blood DNA in such patients. It is also essential to analyze single nucleotide polymorphism (SNP) of candidate gene from accumulated DNA. In the present study we selected some among such kinds of common disease and accumulated DNAs from such patients. We tried to collect the 300 DNAs from the diseases such as BPH, urine tract calculi, genitourinary tract cancer (prostatic cancer, urothelial cancer, kidney cancer, germ cell tumor), We also performed DNA microarray analyses with some study designs for such diseases in order to select candidate gene groups. If causative genes are detected and new idea for the treatment is elucidated in urinary tract calculi, BPH, urinary tract anormalv in infancy and male sex organs, the genitourinary tract cancer, future foundations for the urology are established and further advances for clinical diagnosis and treatment become possible.Blood DNAs are collected in patients with 150 of kidney cancers, 46 of germ cell tumnrs 273 of prostatic cancers, 276 of tumors in the urinary bladder, 141 of PBH, 129 of urine tract calculi, 28 of hypospadia, 9 of VUR, other 56 diseases, and 37 of normality person. Total number reachs to 1145 in this project. We were able to search some candidate genes in DNA microarray analyses in some study designs. Each members also performed a study with their own study project and got some result.
期刊论文(37)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Habuchi T, Ogawa O, et al.: "Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect"Cancer Res. 60. 5710-5713 (2000)
Habuchi T、Okawa O 等人:“前列腺癌和良性前列腺增生的风险增加与具有基因剂量效应的 CYP17 基因多态性相关”。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Inoue K: "The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy"Clin Cancer Res. 6(12). 4866-4873 (2000)
Inoue K:“血管生成因子表达对预测膀胱癌新辅助化疗和根治性膀胱切除术后复发和转移的预后价值”Clin Cancer Res。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kuroda N: "Expression of CD9/molitality-related protein 1(MRP・1) in renal parenchymal neoplasms"Hum pathol. 32(10). 1071-1010 (2001)
Kuroda N:“肾实质肿瘤中 CD9/流动相关蛋白 1(MRP·1)的表达”Hum pathol 32(10)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Fujiwara H, Emi M, Shuin T, Ogawa O et al.: "Association of common missense changes in ELAC2 (HPC2) with prostate cancer in a Japanese case-control series"J. Hum Genet. 47(12). 641-8 (2002)
Fujiwara H、Emi M、Shuin T、Okawa O 等人:“日本病例对照系列中 ELAC2 (HPC2) 中常见错义变化与前列腺癌的关联”J.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kondo K, Hosaka M, et al.: "Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma : relationship to clinicopathological parameters"Genes Chromosome Cancer. 34(1). 58-68 (2002)
Kondo K、Hosaka M 等人:“散发性肾细胞癌中 VHL 基因的综合突变分析:与临床病理学参数的关系”基因染色体癌症。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 35 条
Development of laminin-gamma2 monomer as a potent biomarker for upper urinary tract cancer
-
批准号:17K11144
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2017
-
负责人:SHUIN Taro
-
依托单位:
Clinical development of early detection method for renal cell carcinoma with serum cancer markers and methylated DNA-fragment cancer markers
-
批准号:19390417
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.06万
-
财政年份:2007
-
负责人:SHUIN Taro
-
依托单位:
Basic Strategy for the treatment of kidney cancer : identification and clinical utilization of new tumor suppressor genes or oncogenes closely correlated with VHL gene VHL
-
批准号:16390465
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.15万
-
财政年份:2004
-
负责人:SHUIN Taro
-
依托单位:
Elucidation in the mechanism of human renal cell carcinoma cancer growth and micrometastasis with inactivation of VHL
-
批准号:14370515
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.3万
-
财政年份:2002
-
负责人:SHUIN Taro
-
依托单位:
Molecular detection of kidney cancers with VHL gene mutation in the blood, urine or lymph node
-
批准号:11557118
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.17万
-
财政年份:1999
-
负责人:SHUIN Taro
-
依托单位:
VHL tumor suppressor gene : Identification its function for cell growth inhibition and cell ular apoptosis for kidne cancer to develop new modality of treatment
-
批准号:09470348
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.94万
-
财政年份:1997
-
负责人:SHUIN Taro
-
依托单位:
In vitro expression of von Hippel-Lindau tumor suppressor gene in human renal cell carcinoma by Herpes simplex virus vector
-
批准号:07557105
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$3.58万
-
财政年份:1995
-
负责人:SHUIN Taro
-
依托单位:
Anew trial of Genetic dlagnosisand treatment of kidney cancer based on the abnormallty in the oncogene and tumor suppressor gene Head invastigator ; Registered invastigators : Resgistered
-
批准号:05671330
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1993
-
负责人:SHUIN Taro
-
依托单位: